Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Sensus Healthcare, Inc. SRTS
$2.84
-$0.01 (-0.35%)
На 18:01, 12 мая 2023
+463.38%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
48372896.00000000
-
week52high
15.25
-
week52low
2.29
-
Revenue
44532000
-
P/E TTM
7335
-
Beta
0.63633200
-
EPS
1.51000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 авг 2023 г. в 10:59
Описание компании
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
HC Wainwright & Co. | Buy | Buy | 06 мая 2022 г. |
HC Wainwright & Co. | Buy | Buy | 03 мар 2022 г. |
HC Wainwright & Co. | Buy | Buy | 14 февр 2022 г. |
HC Wainwright & Co. | Buy | Buy | 02 дек 2021 г. |
HC Wainwright & Co. | Buy | Buy | 05 ноя 2021 г. |
Alliance Global Partners | Buy | Buy | 04 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Rampolla Javier | D | 48114 | 742 | 01 февр 2023 г. |
Sardano Michael | D | 55774 | 3745 | 26 янв 2023 г. |
Sardano Michael | A | 59519 | 10000 | 26 янв 2023 г. |
Sardano Michael | D | 49519 | 5000 | 13 сент 2022 г. |
Sardano Michael | A | 54519 | 5000 | 13 сент 2022 г. |
Sardano Joseph C | D | 1130293 | 15794 | 07 сент 2022 г. |
Sardano Joseph C | D | 1146087 | 15794 | 06 сент 2022 г. |
Sardano Joseph C | D | 1161881 | 10000 | 02 сент 2022 г. |
Sardano Joseph C | D | 1171881 | 28999 | 11 авг 2022 г. |
Sardano Joseph C | D | 1200880 | 93320 | 10 авг 2022 г. |
Новостная лента
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
03 мая 2023 г. в 20:32
Sensus Healthcare, Inc. (SRTS) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of $0.11. This compares to earnings of $0.20 per share a year ago.
The 7 Best Stocks Under $10 to Buy in May
InvestorPlace
03 мая 2023 г. в 14:10
While the adage that you get what you pay for generally rings true, you can sometimes cheat up this narrative with the best stocks to buy under $10. While you can't get much for a Hamilton these days, you can acquire shares of surprisingly compelling enterprises.
7 Small-Cap Biotech Stocks with Massive Potential
InvestorPlace
27 апр 2023 г. в 18:36
While unproven biotechnology firms almost always carry significant risks, small-cap biotech stocks in particular typically impose jaw-dropping volatility. Along with the usual risk of clinical disappointments or outright failures, these speculative enterprises are obviously less funded.
Sensus Healthcare to Host First Quarter 2023 Financial Results and Business Update Conference Call on Wednesday, May 3, 2023
GlobeNewsWire
25 апр 2023 г. в 16:05
BOCA RATON, Fla. , April 25, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Wednesday, May 3, 2023 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2023. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
7 Value Stocks to Buy for Long-Term Growth
InvestorPlace
26 мар 2023 г. в 13:50
For investors that have the patience to ride out volatility in exchange for possible long-term upside, value stocks to buy that are discounted against book value may offer considerable intrigue. On paper, book value represents the difference between the company's total assets and total liabilities.